Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. [electronic resource]
Producer: 20210419ISSN:- 2056-5933
- Administration, Oral
- Adult
- Aged
- Antirheumatic Agents -- adverse effects
- Antiviral Agents -- therapeutic use
- Arthritis, Rheumatoid -- complications
- Azetidines -- administration & dosage
- Female
- Hepatitis B -- chemically induced
- Hepatitis B Antibodies -- blood
- Hepatitis B Surface Antigens -- blood
- Hepatitis B virus -- drug effects
- Humans
- Immunomodulation
- Janus Kinase Inhibitors -- administration & dosage
- Japan -- epidemiology
- Latent Infection -- chemically induced
- Male
- Middle Aged
- Purines -- administration & dosage
- Pyrazoles -- administration & dosage
- Retrospective Studies
- Sulfonamides -- administration & dosage
- Tumor Necrosis Factor Inhibitors -- adverse effects
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.